Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Presentation of case/condition: Review of novel agents licensed for use in the 21st century

Date

28 Sep 2019

Session

Is randomisation of clinical trials still the gold standard?

Presenters

Udai Banerji

Authors

U. Banerji

Author affiliations

  • Drug Development Unit  , The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, SM2 5PT - Sutton/GB
More

Resources

Resources from the same session

Why we need randomization

Presenter: Urania Dafni

Session: Is randomisation of clinical trials still the gold standard?

Resources:

Presentation

Webcast

The voice of the regulator (EMA)

Presenter: Francesco Pignatti

Session: Is randomisation of clinical trials still the gold standard?

Resources:

Presentation

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings